Fol. Biol. 2026, 72, 95-108
https://doi.org/10.14712/fb2026.0010
Intravitreal Application of Mesenchymal Stem Cell By-Products Does Not Ameliorate Experimental Autoimmune Uveitis
Eva Uherková1
, Kateřina Palacká2, Eva Škrlová1, Barbora Heřmánková2, Aneta Klímová1, Petra Svozílková1, Vladimír Holáň2, Jarmila Heissigerová1
, Kateřina Palacká2, Eva Škrlová1, Barbora Heřmánková2, Aneta Klímová1, Petra Svozílková1, Vladimír Holáň2, Jarmila Heissigerová1
1Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
2Department of Toxicology and Molecular Epidemiology, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic
Received September 6, 2025
Accepted January 13, 2026
References
1. , P., Mills, S. J., Cowin, A. J. (2020) Mesenchymal stem cell secretome as an emerging cell-free alternative for improving wound repair. Int. J. Mol. Sci. 21, 7038.
<https://doi.org/10.3390/ijms21197038>
2. , L., Shao, H., Wang, H. et al. (2017) Effects of mesenchymal stem cell-derived exosomes on experimental autoimmune uveitis. Sci. Rep. 7, 4323.
<https://doi.org/10.1038/s41598-017-04559-y>
3. , M. A., Sendon-Lago, J., Seoane, S. et al. (2016) Anti-inflammatory effect of conditioned medium from human uterine cervical stem cells in uveitis. Exp. Eye Res. 149, 84-92.
<https://doi.org/10.1016/j.exer.2016.06.022>
4. , R. R., Roberge, F. G., Chan, C. C. et al. (1988) A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J. Immunol. 140, 1490-1495.
<https://doi.org/10.4049/jimmunol.140.5.1490>
5. , M., Le Blanc, K., Mueller, I. et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317.
<https://doi.org/10.1080/14653240600855905>
6. , J. C., Poston, J. N., Balyasnikova, I. et al. (2014) Delayed administration of bone marrow mesenchymal stem cell conditioned medium significantly improves outcome after retinal ischemia in rats. Invest. Ophthalmol. Vis. Sci. 55, 3785-3796.
<https://doi.org/10.1167/iovs.13-11683>
7. , Y., Chen, X., Shao, H. et al. (2024) Enhanced immunosuppressive capability of mesenchymal stem cell-derived small extracellular vesicles with high expression of CD73 in experimental autoimmune uveitis. Stem Cell Res. Ther. 15, 149.
<https://doi.org/10.1186/s13287-024-03764-7>
8. , O., Fajstova, A., Klimova, A. et al. (2020) Severity of experimental autoimmune uveitis is reduced by pretreatment with live probiotic Escherichia coli Nissle 1917. Cells 10, 23.
<https://doi.org/10.3390/cells10010023>
9. , J., Seidler Stangova, P., Klimova, A. et al. (2016) The microbiota determines susceptibility to experimental autoimmune uveoretinitis. J. Immunol. Res. 2016, 5065703.
<https://doi.org/10.1155/2016/5065703>
10. , B., Kossl, J., Bohacova, P. et al. (2019) The immunomodulatory potential of mesenchymal stem cells in a retinal inflammatory environment. Stem Cell Rev. Rep. 15, 880-891.
<https://doi.org/10.1007/s12015-019-09908-0>
11. , B., Kossl, J., Javorkova, E. et al. (2017) The identification of interferon-γ as a key supportive factor for retinal differentiation of murine mesenchymal stem cells. Stem Cells Dev. 26, 1399-1408.
<https://doi.org/10.1089/scd.2017.0111>
12. , V., Palacka, K., Hermankova, B. (2021) Mesenchymal stem cell-based therapy for retinal degenerative diseases: experimental models and clinical trials. Cells 10, 588.
<https://doi.org/10.3390/cells10030588>
13. , K. A., Lobo-Chan, A. M. (2021) Epidemiology and risk factors in non-infectious uveitis: a systematic review. Front. Med. (Lausanne) 8, 695904.
<https://doi.org/10.3389/fmed.2021.695904>
14. , M., Choi, J. K., Jittayasothorn, Y. et al. (2020) Interleukin 35-producing exosomes suppress neuroinflammation and autoimmune uveitis. Front. Immunol. 11, 1051.
<https://doi.org/10.3389/fimmu.2020.01051>
15. , A., Shen, W. Y., Wilson, A. S. et al. (2003) Differentiation of marrow stromal cells into photoreceptors in the rat eye. J. Neurosci. 23, 7742-7749.
<https://doi.org/10.1523/JNEUROSCI.23-21-07742.2003>
16. , A., Seidler Stangova, P., Svozilkova, P. et al. (2016) The critical points in induction of experimental autoimmune uveitis. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 160, 140-142.
<https://doi.org/10.5507/bp.2015.056>
17. , A. M., Zarbin, M. A. (2014) Trophic factors in the pathogenesis and therapy for retinal degenerative diseases. Surv. Ophthalmol. 59, 134-165.
<https://doi.org/10.1016/j.survophthal.2013.09.004>
18. , A. E., Albini, T. A., Townsend, J. H. et al. (2017) Vision loss after intravitreal injection of autologous “stem cells” for AMD. N. Engl. J. Med. 376, 1047-1053.
<https://doi.org/10.1056/NEJMoa1609583>
19. , G., Yuan, L., Ren, X. et al. (2013) The effect of mesenchymal stem cells on dynamic changes of T cell subsets in experimental autoimmune uveoretinitis. Clin. Exp. Immunol. 173, 28-37.
<https://doi.org/10.1111/cei.12080>
20. , Y., Ren, X., Zhang, Z. et al. (2022) Effect of small extracellular vesicles derived from IL-10-overexpressing mesenchymal stem cells on experimental autoimmune uveitis. Stem Cell Res. Ther. 13, 100.
<https://doi.org/10.1186/s13287-022-02780-9>
21. , H., Ong, H. S., Riau, A. K. et al. (2019) Current trends and future perspective of mesenchymal stem cells and exosomes in corneal diseases. Int. J. Mol. Sci. 20, 2853.
<https://doi.org/10.3390/ijms20122853>
22. , B., Poston, J. N., Dreixler, J. C. et al. (2017) Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in rats. Graefes Arch. Clin. Exp. Ophthalmol. 255, 1581-1592.
<https://doi.org/10.1007/s00417-017-3690-1>
23. , M., Jayawardena, T. M., Schmeckpeper, J. et al. (2011) Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J. Mol. Cell. Cardiol. 50, 280-289.
<https://doi.org/10.1016/j.yjmcc.2010.08.005>
24. , E., Anderson, J. D., Oltjen, S. et al. (2017) Protective effect of intravitreal administration of exosomes derived from mesenchymal stem cells on retinal ischemia. Curr. Eye Res. 42, 1358-1367.
<https://doi.org/10.1080/02713683.2017.1319491>
25. , M., Guyomard, J. L., Simonutti, M. et al. (2007) Panretinal, high-resolution color photography of the mouse fundus. Invest. Ophthalmol. Vis. Sci. 48, 2769-2774.
<https://doi.org/10.1167/iovs.06-1099>
26. , S. S., Moisseiev, E., Bauer, G. et al. (2017) Advances in bone marrow stem cell therapy for retinal dysfunction. Prog. Retin. Eye Res. 56, 148-165.
<https://doi.org/10.1016/j.preteyeres.2016.10.002>
27. , Y., Chan, A. M., Chang, Y. L. et al. (2018) Human embryonic stem cell-derived mesenchymal stromal cells decrease the development of severe experimental autoimmune uveitis in B10.RIII mice. Ocul. Immunol. Inflamm. 26, 1228-1236.
<https://doi.org/10.1080/09273948.2017.1343356>
28. , G., Ramadan, A., Abburi, C. et al. (2014) Regenerative therapeutic potential of adipose stromal cells in early stage diabetic retinopathy. PLoS One 9, e84671.
<https://doi.org/10.1371/journal.pone.0084671>
29. , J. T., Bodaghi, B., Couto, C. et al. (2019) New observations and emerging ideas in diagnosis and management of non-infectious uveitis: a review. Semin. Arthritis Rheum. 49, 438-445.
<https://doi.org/10.1016/j.semarthrit.2019.06.004>
30. , P., Dusek, O., Klimova, A. et al. (2019) Metronidazole attenuates the intensity of inflammation in experimental autoimmune uveitis. Folia Biol. (Praha) 65, 265-274.
<https://doi.org/10.14712/fb2019065050265>
31. , T., Oh, J. Y., Kim, D. K. et al. (2017) MSC-derived extracellular vesicles attenuate immune responses in two autoimmune murine models: type 1 diabetes and uveoretinitis. Stem Cell Reports 8, 1214-1225.
<https://doi.org/10.1016/j.stemcr.2017.04.008>
32. , R., Ilengo, C., Quarto, R. et al. (2012) Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 53, 786-793.
<https://doi.org/10.1167/iovs.11-8211>
33. , T., Dastiridou, A., Symeonidis, C. et al. (2018) A focus on the epidemiology of uveitis. Ocul. Immunol. Inflamm. 26, 2-16.
<https://doi.org/10.1080/09273948.2016.1196713>
34. , J. H., Liu, X. L., Sun, J. M. et al. (2020) Role of mesenchymal stem cell derived extracellular vesicles in autoimmunity: a systematic review. World J. Stem Cells 12, 879-896.
<https://doi.org/10.4252/wjsc.v12.i8.879>
35. , H., Koch, P., Chen, M. et al. (2008) A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images. Exp. Eye Res. 87, 319-326.
<https://doi.org/10.1016/j.exer.2008.06.012>
36. , B., Shao, H., Su, C. et al. (2016) Exosomes derived from MSCs ameliorate retinal laser injury partially by inhibition of MCP-1. Sci. Rep. 6, 34562.
<https://doi.org/10.1038/srep34562>
37. , B., Zhang, X., Li, X. (2014) Exosomes derived from mesenchymal stem cells. Int. J. Mol. Sci. 15, 4142-4157.
<https://doi.org/10.3390/ijms15034142>
38. , P. T., Zhang, L. J., Shao, H. et al. (2016) Therapeutic effects of mesenchymal stem cells administered at later phase of recurrent experimental autoimmune uveitis. Int. J. Ophthalmol. 9, 1381-1389.
